The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pembrolizumab for advanced papillary or follicular thyroid cancer: preliminary results from the phase 1b KEYNOTE-028 study.
 
Janice M. Mehnert
Consulting or Advisory Role - Amgen/Dompé (Inst)
Research Funding - Merck (Inst); Merck (Inst); Merck (Inst); Novartis (Inst); polynoma (Inst); Sanofi (Inst)
Other Relationship - Amgen
 
Andrea Varga
Consulting or Advisory Role - Clovis Oncology
 
Marcia Brose
No Relationships to Disclose
 
Rahul Raj Aggarwal
Research Funding - Novartis; Sanofi
 
Chia-Chi Lin
No Relationships to Disclose
 
Amy Prawira
No Relationships to Disclose
 
Filippo de Braud
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Lilly; Merck Serono; Merck Sharp & Dohme; Novartis; SERVIER
 
Kenji Tamura
No Relationships to Disclose
 
Toshihiko Doi
Consulting or Advisory Role - AstraZeneca; Bayer Yakuhin; Chugai Pharma; Kyowa Hakko Kirin; Lilly Japan; Merck Serono; MSD; Nippon Boehringer Ingelheim; Novartis; Otsuka
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Chugai Pharma (Inst); Eisai (Inst); Janssen (Inst); Lilly Japan (Inst); Merck Serono (Inst); MSD (Inst); NanoCarrier (Inst); Novartis (Inst); Pfizer (Inst); Quintiles (Inst); Sanofi (Inst); Sumitomo Group (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst)
 
Sarina Anne Piha-Paul
Research Funding - Abbvie; Bayer; Biomarin; Cerulean Pharma; Curis; Five Prime Therapeutics; GlaxoSmithKline; Helix BioPharma; Incyte; Merck; Novartis; Principa Biopharma; Puma Biotechnology; Samumed; XuanZhu
 
Jill Gilbert
No Relationships to Disclose
 
Sanatan Saraf
Employment - Merck
 
Pradeep Thanigaimani
Employment - Boehringer Ingelheim; Merck
Stock and Other Ownership Interests - Gilead Sciences; Mannkind
 
Jonathan D. Cheng
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Bhumsuk Keam
No Relationships to Disclose